vs
Roivant Sciences Ltd.(ROIV)与REZOLVE AI PLC(RZLV)财务数据对比。点击上方公司名可切换其他公司
Roivant Sciences Ltd.的季度营收约是REZOLVE AI PLC的1.7倍($2.0M vs $1.2M),REZOLVE AI PLC净利率更高(-1078.8% vs -13301.2%,领先12222.4%)
Roivant Sciences Ltd.是一家美国跨国医疗健康企业,2014年由维韦克·拉马斯瓦米创立,现任CEO为马特·格林。公司专注于将技术应用于药物研发领域,同时孵化运营多家生命科学与健康科技子公司,总部位于纽约,在波士顿、巴塞尔两大生物科技产业集群也设有核心办公点。
REZOLVE AI PLC是总部位于英国的科技企业,开发人工智能驱动的移动互动与即时交易平台,支持用户直接从音频、视频、印刷内容中完成购买,服务欧洲、北美及部分亚太市场的零售、消费品与媒体客户。
ROIV vs RZLV — 直观对比
营收规模更大
ROIV
是对方的1.7倍
$1.2M
净利率更高
RZLV
高出12222.4%
-13301.2%
损益表 — Q3 FY2026 vs Q2 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.0M | $1.2M |
| 净利润 | $-265.9M | $-13.0M |
| 毛利率 | — | — |
| 营业利润率 | -16966.1% | -808.4% |
| 净利率 | -13301.2% | -1078.8% |
| 营收同比 | -77.8% | — |
| 净利润同比 | -257.0% | — |
| 每股收益(稀释后) | $-0.38 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ROIV
RZLV
| Q4 25 | $2.0M | — | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $2.2M | $1.2M | ||
| Q1 25 | $-39.6M | — | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $4.5M | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $28.9M | — |
净利润
ROIV
RZLV
| Q4 25 | $-265.9M | — | ||
| Q3 25 | $-113.5M | — | ||
| Q2 25 | $-223.4M | $-13.0M | ||
| Q1 25 | $-206.5M | — | ||
| Q4 24 | $169.4M | — | ||
| Q3 24 | $-230.2M | — | ||
| Q2 24 | $95.3M | — | ||
| Q1 24 | $-151.1M | — |
营业利润率
ROIV
RZLV
| Q4 25 | -16966.1% | — | ||
| Q3 25 | -19492.9% | — | ||
| Q2 25 | -13130.0% | -808.4% | ||
| Q1 25 | 674.8% | — | ||
| Q4 24 | -3042.6% | — | ||
| Q3 24 | -7636.0% | — | ||
| Q2 24 | -1279.5% | — | ||
| Q1 24 | -919.5% | — |
净利率
ROIV
RZLV
| Q4 25 | -13301.2% | — | ||
| Q3 25 | -7225.9% | — | ||
| Q2 25 | -10292.9% | -1078.8% | ||
| Q1 25 | 521.8% | — | ||
| Q4 24 | 1878.3% | — | ||
| Q3 24 | -5143.8% | — | ||
| Q2 24 | 1192.7% | — | ||
| Q1 24 | -522.3% | — |
每股收益(稀释后)
ROIV
RZLV
| Q4 25 | $-0.38 | — | ||
| Q3 25 | $-0.17 | — | ||
| Q2 25 | $-0.33 | — | ||
| Q1 25 | $-0.28 | — | ||
| Q4 24 | $0.23 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $0.12 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.5B | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $4.3B | $-14.3M |
| 总资产 | $5.2B | $80.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ROIV
RZLV
| Q4 25 | $4.5B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.9B | — | ||
| Q4 24 | $5.1B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.7B | — | ||
| Q1 24 | $6.5B | — |
总债务
ROIV
RZLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $311.7M | — | ||
| Q1 24 | $430.6M | — |
股东权益
ROIV
RZLV
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.3B | $-14.3M | ||
| Q1 25 | $4.7B | — | ||
| Q4 24 | $5.2B | — | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $5.4B | — | ||
| Q1 24 | $6.0B | — |
总资产
ROIV
RZLV
| Q4 25 | $5.2B | — | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $5.0B | $80.1M | ||
| Q1 25 | $5.4B | — | ||
| Q4 24 | $5.8B | — | ||
| Q3 24 | $6.2B | — | ||
| Q2 24 | $6.5B | — | ||
| Q1 24 | $7.2B | — |
负债/权益比
ROIV
RZLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-196.5M | $-4.9M |
| 自由现金流经营现金流 - 资本支出 | $-201.4M | — |
| 自由现金流率自由现金流/营收 | -10076.0% | — |
| 资本支出强度资本支出/营收 | 246.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-776.7M | — |
8季度趋势,按日历期对齐
经营现金流
ROIV
RZLV
| Q4 25 | $-196.5M | — | ||
| Q3 25 | $-185.7M | — | ||
| Q2 25 | $-204.4M | $-4.9M | ||
| Q1 25 | $-172.6M | — | ||
| Q4 24 | $-207.3M | — | ||
| Q3 24 | $-266.8M | — | ||
| Q2 24 | $-192.8M | — | ||
| Q1 24 | $-108.5M | — |
自由现金流
ROIV
RZLV
| Q4 25 | $-201.4M | — | ||
| Q3 25 | $-193.5M | — | ||
| Q2 25 | $-208.4M | — | ||
| Q1 25 | $-173.4M | — | ||
| Q4 24 | $-209.1M | — | ||
| Q3 24 | $-267.8M | — | ||
| Q2 24 | $-193.8M | — | ||
| Q1 24 | $-108.8M | — |
自由现金流率
ROIV
RZLV
| Q4 25 | -10076.0% | — | ||
| Q3 25 | -12317.8% | — | ||
| Q2 25 | -9604.5% | — | ||
| Q1 25 | 438.1% | — | ||
| Q4 24 | -2318.5% | — | ||
| Q3 24 | -5984.4% | — | ||
| Q2 24 | -2425.5% | — | ||
| Q1 24 | -376.1% | — |
资本支出强度
ROIV
RZLV
| Q4 25 | 246.9% | — | ||
| Q3 25 | 499.6% | — | ||
| Q2 25 | 185.9% | — | ||
| Q1 25 | -2.0% | — | ||
| Q4 24 | 20.3% | — | ||
| Q3 24 | 22.3% | — | ||
| Q2 24 | 12.1% | — | ||
| Q1 24 | 1.2% | — |
现金转化率
ROIV
RZLV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1.22× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -2.02× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图